MEPILEX AND/OR MEPILEX AG
Report
- Report Number
- 3004763499-2013-00019
- Event Type
- Death
- Date Received
- October 30, 2013
- Date of Event
- March 28, 2013
- Report Date
- October 29, 2013
- Manufacturer
- MOLNLYCKE HEALTH CARE
- Product Code
- FRO
- PMA / PMN Number
- EXEMPT
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER
Narratives
THIS WAS A DOUBLE-BLINDED, COMPARATIVE, SUPERIORITY, MULTI-CENTER CLINICAL INVESTIGATION OF MEPILEX AND MEPILEX AG CONDUCTED IN (B)(4). BASED ON THE AVAILABLE INFO, THIS EVENT IS DEEMED A SERIOUS INJURY. AS THIS WAS A DOUBLE-BLINDED STUDY WE ARE NOT AT THIS TIME SURE OF WHICH OF THE DEVICES WAS USED ON THIS SUBJECT. THEREFORE, WE HAVE REPORTED ON BOTH PRODUCTS. NO ADD'L PT / EVENT INFO HAS BEEN PROVIDED TO DATE. THE INVESTIGATORS ASSESSMENT OF RELATIONSHIP OF SUBJECT INCIDENT RELATION TO PRODUCT IS UNLIKELY. SHOULD ADD'L INFO BECOME AVAILABLE, A F/U REPORT WILL BE SUBMITTED.
PT WAS ENROLLED IN A DOUBLE-BLINDED, COMPARATIVE, SUPERIORITY, MULTI-CENTER CLINICAL INVESTIGATION OF MEPILEX AND MEPILEX AG. THE SUBJECT DIED FROM CARDIAC DECOMPENSATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 556127 | MEPILEX AND/OR MEPILEX AG | MEPILEX AND/OR MEPILEX AG | FRO | MOLNLYCKE HEALTH CARE | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | UNK | Death |